These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3017406)

  • 21. Photoaffinity labeling of the glucagon receptor with a new glucagon analog.
    Wright DE; Horuk R; Rodbell M
    Eur J Biochem; 1984 May; 141(1):63-7. PubMed ID: 6327311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coupling of the glucagon receptor to adenylate cyclase.
    Houslay MD
    Biochem Soc Trans; 1979 Oct; 7(5):843-6. PubMed ID: 229036
    [No Abstract]   [Full Text] [Related]  

  • 23. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
    Andreu D; Merrifield RB
    Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of surface charge and hydrophobic interaction in the activation of rat liver adenylate cyclase.
    Rubalcava B; Grajales MO; Cerbon J; Pliego JA
    Biochim Biophys Acta; 1983 Sep; 759(3):243-9. PubMed ID: 6309252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational and biological properties of di[delta-(5-nitro-2-pyrimidyl)ornithine 17,18]glucagon. Role of the arginine residues.
    Epand RM; Liepnieks JJ
    J Biol Chem; 1983 Jan; 258(1):203-7. PubMed ID: 6294099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.
    Houslay MD; Metcalfe JC; Warren GB; Hesketh TR; Smith GA
    Biochim Biophys Acta; 1976 Jun; 436(2):489-94. PubMed ID: 179598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of glucagon receptors in Golgi fractions of rat liver: evidence for receptors that are uncoupled from adenylyl cyclase.
    Lipson KE; Kolhatkar AA; Cherksey BD; Donner DB
    Biochemistry; 1986 May; 25(9):2612-20. PubMed ID: 3013309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of cholera toxin and the mobile receptor theory of hormone receptor-adenylate cyclase interactions.
    Bennett V; O'Keefe E; Cuatrecasaş P
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):33-7. PubMed ID: 164020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of the hepatic glucagon receptor. Identification of a guanine nucleotide-sensitive hormone-binding region.
    Iyengar R; Herberg JT
    J Biol Chem; 1984 Apr; 259(8):5222-9. PubMed ID: 6325424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships.
    Mahrenholz AM; Flanders KC; Hoosein NM; Gurd FR; Gurd RS
    Arch Biochem Biophys; 1987 Sep; 257(2):379-86. PubMed ID: 2821912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
    Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
    J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of the mouse major histocompatibility complex, H-2, on liver adenylate cyclase activity and on glucagon binding to liver cell membranes.
    Lafuse W; Edidin M
    Biochemistry; 1980 Jan; 19(1):49-54. PubMed ID: 6243475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An improved synthesis of crystalline mammalian glucagon.
    Mojsov S; Merrifield RB
    Eur J Biochem; 1984 Dec; 145(3):601-5. PubMed ID: 6510418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model.
    Houslay MD; Ellory JC; Smith GA; Hesketh TR; Stein JM; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1977 Jun; 467(2):208-19. PubMed ID: 195604
    [No Abstract]   [Full Text] [Related]  

  • 37. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
    Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
    Wright DE; Hruby VJ; Rodbell M
    Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonist.
    Wright DE; Hruby VJ; Rodbell M
    J Biol Chem; 1978 Sep; 253(18):6338-40. PubMed ID: 210180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.
    Hruby VJ
    Mol Cell Biochem; 1982 Apr; 44(1):49-64. PubMed ID: 6283336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.